| RS1592408302 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS1592409631 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS1592409633 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS1592409736 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592409876 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592410003 |
PYGM
|
Health Risk |
Pathogenic |
Glycogen storage disease, type V |
| RS1592410540 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS1592410582 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592411896 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592412022 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592412131 |
PYGM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type V |
| RS1592414464 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592415275 |
CNTN1
|
Health Risk |
Pathogenic |
Compton-North congenital myopathy, Compton-North congenital myopathy |
| RS1592415563 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592415625 |
PAX6
|
Health Risk |
Pathogenic |
— |
| RS1592415745 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592415868 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592415958 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592416305 |
PAX6
|
Health Risk |
Pathogenic |
Irido-corneo-trabecular dysgenesis, Aniridia 1 |
| RS1592416453 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1592416538 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1592420967 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592421398 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592421981 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592422097 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592422740 |
F2
|
Health Risk |
Likely pathogenic |
Prolonged prothrombin time, Prolonged prothrombin time |
| RS1592424894 |
LEMD3
|
Health Risk |
Pathogenic |
— |
| RS1592425446 |
LEMD3
|
Health Risk |
Pathogenic |
— |
| RS1592432969 |
PAX6
|
Health Risk |
Likely pathogenic |
— |
| RS1592433022 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592433545 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592433606 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592433640 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1592434096 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592435423 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592435527 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592435632 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592435653 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1592464882 |
LEMD3
|
Health Risk |
Likely pathogenic |
Dermatofibrosis lenticularis disseminata, Dermatofibrosis lenticularis disseminata |
| RS1592475699 |
STAT2
|
Health Risk |
Pathogenic |
Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection, Primary immunodeficiency with post-measles-mumps-rubella vaccine viral infection |
| RS1592490234 |
SYNE1
|
Health Risk |
Pathogenic |
Emery-Dreifuss muscular dystrophy 4, autosomal dominant |
| RS1592491950 |
BBS10
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 10, Bardet-Biedl syndrome |
| RS1592492255 |
BBS10
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 1, Bardet-Biedl syndrome 1 |
| RS1592493118 |
BBS10
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 10 |
| RS1592495200 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS1592496317 |
ITGA7
|
Health Risk |
Likely pathogenic |
Congenital muscular dystrophy due to integrin alpha-7 deficiency, Congenital muscular dystrophy due to integrin alpha-7 deficiency |
| RS1592513048 |
AAAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Glucocorticoid deficiency with achalasia, Germ cell tumor of testis |
| RS1592521438 |
RDH5
|
Health Risk |
Pathogenic |
Pigmentary retinal dystrophy, Pigmentary retinal dystrophy |
| RS1592521712 |
RDH5
|
Health Risk |
Pathogenic |
Pigmentary retinal dystrophy, Pigmentary retinal dystrophy |
| RS1592530126 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592530379 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592530521 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592531953 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592532084 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1592532169 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1592532561 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592532580 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1592542002 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592542060 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592542273 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592542343 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592542615 |
PAX6
|
Health Risk |
Pathogenic |
— |
| RS1592542705 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592542942 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592543032 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592543499 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592543841 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592544327 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592544553 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592545392 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592545972 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592546024 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592546120 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1592546273 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592546340 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592546566 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592546589 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592550848 |
CEP290
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1592562717 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592562836 |
PAX6
|
Health Risk |
Pathogenic/Likely pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1592562910 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592563047 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592563240 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1592563333 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592563428 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1592563502 |
PAX6
|
Health Risk |
Pathogenic |
— |
| RS1592563636 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592563721 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592564013 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592564157 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592564219 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592564313 |
PAX6
|
Health Risk |
Pathogenic |
Irido-corneo-trabecular dysgenesis, Aniridia 1 |
| RS1592564366 |
PAX6
|
Health Risk |
Likely pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592564672 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS1592564908 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |
| RS1592574519 |
CEP290
|
Health Risk |
Pathogenic |
Meckel-Gruber syndrome, Nephronophthisis |
| RS1592582910 |
PTPRQ
|
Health Risk |
Likely pathogenic |
— |
| RS1592602849 |
MDM2
|
Health Risk |
Likely pathogenic |
Lessel-kubisch syndrome, Accelerated tumor formation |
| RS1592610121 |
PAX6
|
Health Risk |
Pathogenic |
Congenital aniridia, Irido-corneo-trabecular dysgenesis |
| RS1592610205 |
PAX6
|
Health Risk |
Pathogenic |
Aniridia 1, Aniridia 1 |